
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy
Keywords: بازدارنده; Glycogen; Phosphorylase; Inhibitor; Anthranilimide; Glucagon; Challenge; Antidiabetic